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Schistosomiasis is an important tropical disease aﬀecting approximately 200 million people worldwide. Because of its chronicity
and robust immunomodulatory activity, the eﬀects of schistosomes on other diseases, such as allergies, autoimmunity, and
infectious diseases, have been studied extensively in both epidemiological and experimental settings. In this paper, we summarize
the beneﬁcial and harmful eﬀects of schistosomes. The importance of controlling schistosomiasis is also discussed.
1.Introduction
Schistosoma spp., blood ﬂukes, are parasitic helminths found
mainly in developing countries with a tropical or subtropical
climate and aﬀect 200 million people worldwide [1]. Schis-
tosoma mansoni, japonicum, and mekongi harbor in veins
of the portal system and lay eggs in the blood vessels. The
depositionofnumerouseggsintheintestinesandliverresults
in intestinal and hepatic granulomatous lesions, ﬁbrosis,
portal hypertension, and hepatosplenomegaly. In contrast,
Schistosoma haematobium mainly harbors in the venous
plexusofthebladderand/orrectalvenousplexus.Thisworm
usually causes bloody urine but is also considered to have
an etiological relationship with bladder cancer [2]. Because
of the extensive distribution of schistosomes and morbidity
due to egg deposition, researchers have been interested in the
inﬂuences of schistosome infections on concomitant diseases
[3]. As mentioned, S. haematobium is an important car-
cinogenic factor of bladder cancer although the worm itself
does not have mutagenic activity [4]. This parasite is also
suggested to be a risk factor for the transmission of HIV [5].
These eﬀects are attributable to pathological lesions caused
by the parasites. On the other hand, most helminthic para-
sites including schistosomes are known to induce robust
Th2-polarization. Especially in schistosome infections, egg
deposition in the host tissues was reported to be the major
stimulus of Th2 responses [6], and egg proteins (e.g.,
omega-1, IPSE, and peroxiredoxin) are involved in the
Th2-biasing activity [7–11]. In addition, schistosome eggs
have immunomodulatory potential inducing the alternative
activation of macrophages [12] and regulatory T-cell expan-
sion [13]. Because of its robust systemic Th2-inducing and
immunomodulatory ability, this worm has been studied
mostextensivelyforitsbystandereﬀectsonvariousimmuno-
logical phenomena in vivo. In this paper, we summarize the
eﬀects of a concurrent infection of schistosomes on im-
munological disorders and parasitic/microbial infections.
2. Effects of Schistosomes on
Immunological Disorders or Infectious
DiseasesinMice andHumans
2.1. Allergy. Eﬀects of helminths (including schistosomes)
on allergic diseases have been studied extensively in both ex-
perimental and epidemiological settings. In experimental
asthmaorairwayhypersensitivitymodels,schistosomeinfec-
tions and antigen administrations have been consistently
shown to protect the animals from the diseases (Table 1). In
most studies on the antiasthmatic eﬀects of schistosomes,
cellular inﬁltration (including eosinophils) into broncho-
alveolar lavage ﬂuid (BALF) was diminished and simultane-
ously IL-4, IL-5, and IgE levels were reduced. In contrast, an
increase in Treg cells and augmentation of IL-10 production2 Journal of Biomedicine and Biotechnology
were observed. Fallon and Mangan [14] designated this kind
of Th2 response (Treg dominant and IL-10 dominant) a
“modiﬁed Th2 response” as opposed to the conventional
“allergic Th2 response.” They demonstrated that in infected
mice, IL-10-producing CD1dhigh B cells induce Treg cells
and consequently ameliorate allergic airway inﬂammation
[15]. In the study, IL-10 was indispensable to the eﬀects of
schistosomes. The authors also showed the importance of B
cells, and IL-10 in the suppression of systemic anaphylaxis by
schistosomes [16] .S m i t se ta l .[ 17] found that in adoptive
transfer experiments, spleen cells (especially B cells and
CD4+ T cells) from chronically infected mice could confer
protection against pulmonary inﬁltration by white blood
cells, especially eosinophils. In addition, administration of
anti-IL-10R antibody cancelled out the eﬀects of the cell
transfer. These studies seem to support the critical impor-
tance of B cells, Treg cells and IL-10 in schistosome-induced
protection against airway allergic inﬂammation. In studies
by another group, however, IL-10 signaling was not essential
for the antiallergic immunomodulation by schistosomes [18,
19]. The reason for this discrepancy is unclear, but as the au-
thors point out, other immunomodulatory factors may be
able to compensate the absence of IL-10 [19].
Antiallergic eﬀects of schistosomes have also been demo-
nstratedinhumans.InastudyinBrazil,bothasthmaticsym-
ptoms and skin reactivity to indoor allergens were reduced
in S. mansoni-infected asthmatics compared to non-infected
individuals [42]. In another study, higher expression levels of
HLA-DR, IL-10R (in monocytes), CTLA-4 and CD40L (in
CD4+ T cells) were observed in S. mansoni-infected asth-
matics [43]. According to that paper, the main sources of IL-
10 were monocytes and Treg cells. A meta-analysis of cur-
rent parasite infections and atopy [44] revealed that schsito-
somiasis was protective against allergic skin sensitization as
well as some other helminths (Ascaris lumbricoides, Trichuris
trichiura, hookworm). The same research group also report-
ed a meta-analysis of interrelationships between helminths
and asthma [45]. Hookworm infections were shown to be
protective, but no beneﬁcial eﬀect was found for schistosome
infections,probablyduetotheinsuﬃcientnumberofstudies
(onlytwo).Collectively,anti-asthmaticeﬀectsofschistosom-
es have been conﬁrmed in animal models and suppressive
eﬀects on allergic skin reactivity have been conﬁrmed in
humans. However, more epidemiological (especially inter-
vention) studies are necessary to conclude whether schis-
tosome infections have beneﬁcial or detrimental eﬀects on
asthmatic patients.
2.2. Autoimmunity. Autoimmune disorders had been con-
sidered Th1-mediated diseases for a long time. As the Th2-
biasing ability of parasitic helminths and consequent down-
regulation of Th1 responses have been well known, antiau-
toimmune eﬀectsofsuchparasiteshadbeenattributedtothe
downregulation of Th1 responses in infected animals. How-
ever, some major autoimmune diseases are now considered
to be dependent on Th17, a newly found pathogenic T-cell
subsetthatmainlyproducesIL-17[46].Withthisﬁnding,the
antiautoimmunepropertiesofhelminthshavebeenrevisited.
In recent years, downmodulation of Th17 responses by para-
sitic helminths has been reported [24, 36, 47, 48]. If the sup-
pressive activity on both Th1 and Th17 is common to para-
sitic helminths, helminths may become ideal sources of drug
screeningfortreatmentofautoimmunedisorders.Thatisbe-
cause both T-cell subsets are involved in the pathogenesis
of some autoimmune diseases [49]. Moreover, the unstable
nature of Th17 [49] reinforces this idea.
As summarized in Table 1,s c h i s t o s o m e ss u p p r e s sv a ri o u s
autoimmunity models in rodents. An upregulation of IL-4
and downregulation of IFN-γ responses are almost com-
monlyobserved.Inaddition,responsesofIL-17and/orTNF-
α, both of which play pathological roles in autoimmune
arthritis [24, 26] and hapten-induced colitis [36, 40], were
alsodownregulatedbyschistosomeinfections.Moreover,our
study in mice with collagen-induced arthritis (CIA) revealed
that the disease-associated local augmentation of bone-des-
tructive cytokines (i.e., IL-6 and RANKL) was abrogated in
infected animals [24]. These results indicate that schistoso-
m e sh a v es u p p r e s s i v ee ﬀects on both Th1/Th17 and inﬂam-
matory cytokines. In addition, schistosomes suppress other
pathogenic mediators such as autoreactive antibodies. Schis-
tosomes decreased levels of anti-insulin IgG [30], anti-TSHR
IgG2a [41], and anticollagen IgG [24, 25]. This eﬀect was
also observed in humans, as Mutapi et al. recently reported
that S. haematobium infection intensity was inversely related
to autoreactive antinuclear antibody (ANA) levels [50]. The
authors also found that antihelminthic treatment increased
ANA levels. However, Rahima et al. reported the presence of
antinuclear antibodies in S. mansoni-infected mice and that
sera from patients with systemic lupus erythematosus (SLE)
reacted with cercarial antigens [51], suggesting that schisto-
somes trigger some kinds of autoimmunity. In conclusion,
large-scale cross-sectional studies may be necessary to reveal
the interrelationships between schistosomiasis and autoim-
munity.
It is reasonable to hypothesize that the downmodulation
of proinﬂammatory cytokines and pathogenic antibodies is
involved in the antiautoimmune activity of schistosomes, at
least partially. As regulatory cytokines are known to down-
regulate proinﬂammatory cytokines and pathogenic anti-
bodies, it is important to determine the “essential” regula-
tory cytokines in each disease models for elucidation of sup-
pressive mechanisms. For this purpose, it is necessary to per-
form experiments of cytokine neutralization with speciﬁc
antibodies or experiments using gene-targeted animals. In
Th1/Th17-dependent autoimmunity, IL-4, the key cytokine
of Th2 responses, may be responsible for the alleviation of
the disease symptoms. For instance, by using gene-targeted
mice, STAT6 (a key signaling molecule in the response to
IL-4 and IL-13) was shown to be indispensable to the S.
mansoni egg-induced suppression of experimental autoim-
mune encephalomyelitis (EAE) [28] and of TNBS-induced
colitis [35]. In contrast, IL-4 and IL-13 were dispensable to
the suppression of DSS-induced colitis (Th2 cytokine dom-
inant and macrophage-mediated colitis) by male worms of
S. mansoni [39]. In the same study, authors demonstrated
that IL-10 and TGF-β were also dispensable to the anticolitic
eﬀectsofschistosome,byusingspeciﬁcantibodiesagainstIL-
10R and TGF-β. IL-10 was not a crucial regulatory cytokineJournal of Biomedicine and Biotechnology 3
Table 1: Suppressive eﬀects of schistosome on experimental allergy and autoimmunity in rodents.
Category of
animal models Diseases Schistosome Treatment Proposed mechanisms Refs
Allergy Asthma/Airway hypersensitivity
or inﬂammation Sm Infection (male) IL-5 ↓,I L - 1 0 ↑ [20]
Infection, Egg i.p. IL-4 ↓,I L - 5↓,I g E↓,T r e g ↑,
Independent of IL-10 [18]
Infection (chronic) Bc e l l sa n dC D 4 + Tc e l l s ,
Dependent on IL-10 [17]
Infection and Adoptive
transfer
IL-10-producing CD1dhigh Bc e l l s
→ Treg↑ [15]
Sm22.6, PIII IL-4 ↓,I L - 5↓,I g E↓,T r e g↑,
independent of IL-10 [19]
Sj Infection (male, mixed) IL-4 ↓,I L - 5↓,I g E↓,I L - 1 0↑ [21]
Infection and adoptive
transfer DC → IL-4 ↓,I L - 5↓,I L - 1 0↑ [22]
Sj SEA, Eggs (i.p., p.o.) Treg↑ [23]
Systemic anaphylaxis Sm Infection IL-10-producing B cell [16]
Autoimmunity Collagen-induced arthritis (CIA) Sm Infection IL-17 ↓,T N F - α ↓,I L - 6↓,
RANKL ↓, anticollagen IgG ↓ [24]
Sj Infection IL-4 ↑, anticollagen IgG ↓ [25]
Adjuvant-induced arthritis (AIA) Sj Sj16 i.p. TNF-α ↓,I L - 1 β ↓,N O↓,I L - 1 0↑ [26]
Experimental autoimmune
encephalomyelitis (EAE) Sm Infection IL-12p40 ↓,I F N - γ ↓,T N F - α ↓,
IL-4 ↑ [27]
Egg i.p. IFN-γ ↓,I L - 4↑,T G F - β ↑,
IL-10 ↑, dependent on STAT6 [28]
Sj SEA i.p. IFN-γ ↓,I L - 4↑ [29]
Type 1 diabetes in NOD mice Sm Infection, Egg i.p. Inhibition of Ab class switch
(anti-insulin IgG ↓) [30]
SEA, SWA i.p. NKT ↑ [31]
SEA i.p. Treg ↑ [32]
Streptozotocin-induced diabetes
(multiple low dose) Sm Infection [33]
TNBS-induced colitis Sm Infection IL-2 ↑,I L - 4↑ [34]
Egg i.p. IFN-γ ↓,I L - 4↑,d e p e n d e n to n
STAT6 [35]
SWA i.p. IFN-γ ↓,I L - 1 7↓,T G F - β ↑,
IL-10 ↑ [36]
Sj Egg i.p. IFN-γ ↓,I L - 4↑,I L - 1 0↑,T r e g↑ [37]
Egg i.p. IFN-γ ↓,I L - 4↑, TLR4 ↓ [38]
DSS-induced colitis Sm Infection (male)
Dependent on macrophages,
independent of Treg, IL-10, IL-4,
IL-13 and TGF-β
[39]
Infection TNF-α ↓ [40]
Grave’s hyperthyroidism Sm Infection Anti-TSHR IgG2a ↓ [41]
↓: down-regulation, ↑: up-regulation, Sm: S. mansoni,S j :S. japonicum.
also in other helminthic infections, that is, piroxicam-induc-
ed colitis was suppressed by Heligmosomoides polygyrus [48],
and EAE was suppressed by Fasciola hepatica [47], both in
IL-10-deﬁcient mice. In the latter study, however, TGF-β was
shown to be responsible for anti-EAE eﬀects of the worms
[47]. Taken together, the involvements of IL-4, IL-10, and
TGF-β in antiautoimmune eﬀects of helminths depend on
the disease models and helminth species. Further investiga-
tions using various autoimmunity models and gene-targeted
animalswouldbenecessaryforcomprehensiveelucidationof
thesuppressivemechanisms byregulatorycytokines inschis-
tosome infections.
Regarding the participation of regulatory cell popula-
tions in schistosome-induced antiautoimmune eﬀects, Treg
cells, macrophages, and other types of cells (e.g., NKT cells)
have been suggested. Although Treg cell population is known
to expand by schistosome infection or SEA administration
[13, 32], their involvement seems to depend on the disease4 Journal of Biomedicine and Biotechnology
models. For instance, Cooke et al. have been studying anti-
diabetic eﬀects of S. mansoni using a spontaneous T1D
m o d e l( N O Dm o u s e )[ 30], and they demonstrated that Treg
cells were essential in the suppression of T1D by cell transfer
experiments [32]. The authors (Zaccone et al.) showed that
splenocytes from nontreated NOD mice successfully trans-
mitted diabetes into NOD/SCID recipients, whereas spleno-
cytes from SEA-treated NOD mice had a reduced capacity
to transmit diabetes. They also showed that SEA had vari-
ous immunomodulatory eﬀects on dendritic cells (DCs),
macrophages,andTcellsofNODmice[12,32]:forexample,
increased expressions of TGF-β,g a l e c t i n s ,P D - L 1 ,a n ds o
forth.IncontrasttothisT1Dmodel,Smithetal.showedthat
depletionofTregcellsdidnotinﬂuencethesuppressiveeﬀect
of schistosomes on DSS-induced colitis [39]. They demon-
strated that macrophages (but NOT alternatively activated
macrophages) played an essential role in the amelioration of
the colitis.
In some of the studies in Table 1, the injection of eggs
or SEA was not eﬀective [27, 39, 40]. Likewise, in our study
of CIA, SEA injection was not eﬀective [52]. Taken together
with ﬁndings that mice infected with male worms become
resistant to DSS-induced colitis [39], egg-derived substances
are not suﬃcient to explain all of the immunomodulatory
activities of schistosomes. Indeed, injection of soluble worm
antigens (SWAs) could prevent T1D in NOD mice [31]a n d
TNBS-induced colitis [36]. Therefore, diﬀerential eﬀects of
worms and eggs should be further elucidated for a precise
understanding of the immunomodulatory mechanisms of
schistosomes. In addition, further studies on diﬀerences bet-
ween single-sex infections and mixed-sex infections may be
necessary.
2.3. Parasitic Infections. In tropical developing countries, in-
fectionswithmultiplemicrobes/parasitesarecommon.Con-
sequently, the immune responses and/or pathological lesions
caused by one pathogen may aﬀect the outcome of other
infections. Therefore, inﬂuences of parasitic infections on
concomitant diseases have been studied. In this section, we
focus on the eﬀects of schistosomes on other parasitic infec-
tions. Malaria is the world’s deadliest and most widely dis-
tributed parasitic disease. Consequently, there are more than
a few experimental studies on the interrelationships between
schistosomiasisandmalaria(Table2).Theinﬂuenceofschis-
tosome infections depends on the species of the malarial par-
asites and mouse strains used in the experiments. For instan-
ce, in CBA/Ca mice, S. mansoni protected against P. chabaudi
infection, worsened P. yoelii infection, and had no eﬀect on
P. berghei infection [53]. Even when the same parasite,
P. chabaudi, was used, schistosomes exacerbated the parasi-
temia and mortality in C57BL/6 mice but ameliorated the
outcome in A/J mice [54, 55]. Although these complicated
outcomes should be taken into consideration, in general,
schistosome infections seem to exacerbate rodent malaria,
that is, increase of parasitemia, mortality, and hepatospleno-
megaly[56].Detrimentaleﬀectsofschistosomeinfectionson
malarial outcome are also reported in humans [57, 58]. In
Kenyan school children, even a light S. mansoni infection
was shown to exacerbate hepatosplenomegaly of malarial
patients [57]. In a study in Senegal, heavy S. mansoni infec-
tions signiﬁcantly increased the incidence of malarial attacks
[58]. However, the modiﬁcation of antibody responses by
concomitant schistosomiasis is controversial [59, 60]. The
mechanism responsible for the exacerbation (or ameliora-
tion) of malaria is clear in neither mice nor humans. Helmby
et al. [54] suggested diminished production of TNF-α in
schistosome-infected mice to have contributed to the
increase in parasitemia of P. chabaudi. Yoshida et al. exten-
sively analyzed possible mechanisms of protective eﬀects of
schistosomes against P. chabaudi in A/J mice [55]. They ob-
served an enhanced Th1 response to P. chabaudi in schis-
tosome-infected mice and that an anti-IFN-γ antibody abro-
gated the schistosome-induced protective eﬀect against
P. chabaudi. As monoinfection with S. mansoni induced a
Th2-dominant response, upregulation of IFN-γ seemed to
derive from the mixed infections of both parasites. They also
observed the upregulation of iNOS gene expression in spleen
from mice with mixed infections, suggesting an increase
of splenic nitric oxide production to have contributed to
the protection from P. chabaudi. Although the mechanism
of the exacerbation of rodent malaria by schistosome is
yet to be suﬃciently analyzed, Treg cells have been shown
to play an important role in the exacerbation of P. yoelii
infection by preceding H. polygyrus infection [61]. Like-
wise, the induction/expansion of Treg cells by schistosome
might be involved in the increased susceptibility to rodent
malaria. The Th1 immune response protects against malarial
parasites, but it also plays pathological roles in malaria,
especially cerebral malaria [62]. Thus, schistosome as a
representative Th2-biasing helminth is expected to suppress
brain pathology. Indeed, in a model of cerebral malaria
using mice infected with P. berghei ANKA, S. mansoni
reduced the incidence of cerebral malaria and delayed death
[63]. Moreover, the administration of IPSE/alpha-1, a Th2-
inducingschistosomaleggprotein[9,10],alsodelayeddeath.
Bucher et al. reported that brain pathology was reduced in
schistosome-infectedmicealthoughtheydidnotobserveany
beneﬁcial eﬀect on mortality [64].
Inﬂuence of schistosomes on other protozoan infections
has also been investigated (Table 2). Regarding Leishmania
major, reports vary, with Yoshida et al. ﬁnding no eﬀects of
schistosome on the outcome of L. major infection [67], and
La Flamme et al. reporting an exacerbation of experimental
leishmaniasis [68]. The reason for the discrepancy is not
clear but might be intensity of the S. mansoni infection (20
cercariae in the former versus 70 cercariae in the latter).
In the case of L. donovani, schistosome-preinfected mice
failed to control growth of the protozoa in the liver [70]. In
the coinfected mice, hepatic egg granulomas were shown to
provide a favorable microenvironment for the growth of the
amastigotes. Likewise, S. mansoni exacerbated Trypanosoma
cruzi infection [71]a n dToxoplasma gondii infection [72].
In general, schistosome infections seem to be detrimental to
animals infected with protozoan parasites.
In marked contrast to that for protozoan parasites,
protective immunity against intestinal helminths is usually
Th2 dependent. Therefore, the Th2-dominant environmentJournal of Biomedicine and Biotechnology 5
Table 2: Eﬀects of schistosome on other parasitic infections in rodents.
Category Parasites Schistosome Mouse strain Eﬀects Refs.
Malaria Plasmodium berghei Sm CBA/Ca No eﬀect [53]
Plasmodium berghei ANKA Sm Swiss albino Parasitemia ↑,m o r t a l i t y↑ [65]
Plasmodium berghei NK65 Sm BALB/c Parasitemia ↑,m o r t a l i t y↑ [66]
Plasmodium chabaudi Sm CBA/Ca Parasitemia ↓ [53]
Plasmodium chabaudi AS Sm A/J Mortality ↓ [55]
C57BL/6 Parasitemia ↑,m o r t a l i t y↑
Sm C57BL/6 Parasitemia ↑ [54]
Plasmodium yoelii Sm CBA/Ca Parasitemia ↑ [53]
Sm BALB/c Parasitemia ↑,m o r t a l i t y↑ [56]
Cerebral Malaria Plasmodium berghei ANKA Sm ICR HSD Cerebral malaria ↓ [63]
Sm C57BL/6 Brain pathology ↓,n oe ﬀect on mortality [64]
Other protozoan
infections Leishmania major Sm BALB/c No eﬀect [67]
C57BL/6 No eﬀect
Sm C57BL/6 Parasitemia ↑, lesion resolution delayed [68]
Leishmania mexicana Sm Outbred Incubation period shortened [69]
Leishmania donovani Sm C57BL/6 Parasitemia ↑ [70]
Trypanosoma cruzi Sm Albino Parasitemia ↑,m o r t a l i t y↑ [71]
Toxoplasma gondii Sm Albino Mortality ↑ [72]
Helminthic
infections Hymenolepis diminuta Sm NMRI Expulsion ↑ [73]
Strongyloides venezuelensis Sm C57BL/6 Migration ↓ [67]
Sj C57BL/6 Migration ↓, expulsion ↑ [69]
Trichuris muris Sm AKR Expulsion ↑ [74]
↓: downregulation, ↑: upregulation; Sm: S. mansoni,S j :S. japonicum.
produced by schistosomes can be expected to protect against
intestinalhelminths.Indeed,assummarizedinTable2,schis-
tosome infections protected mice from intestinal helminths.
Likewise, in a human study in Brazil [75], S. mansoni egg
counts were inversely correlated with A. lumbricoides and T.
trichiura.( O n ee x c e p t i o nw a sAncylostoma, which was posi-
tively correlated with schistosome infections). Although pro-
tection against intestinal helminths is commonly observed in
experimental settings, the mechanisms diﬀer in each case.
For instance, protection against a lung-migratory parasite,
Strongyloidesvenezuelensis,mainlyinvolvedeosinophil-med-
iated killing of larvae in the lungs [76]. In addition, intes-
tinalmucosalmastocytosisinducedbyS.japonicuminfection
rendered mice resistant to harboring of adult worms [76].
Antigen cross-reactivity between schistosomes and S. vene-
zuelensis [67, 76] may have also contributed to the protec-
tion. In contrast, in the case of Hymenolepis diminuta and
Trichuris muris (nonmigratory intestinal helminths), the
protection seems to be dependent on accelerated expulsion
from the intestines [73, 74]. Overall, schistosome infections
appear to be beneﬁcial to animals infected with intestinal
helminths.
2.4. Bacterial Infections and Vaccinations. Prolonged bac-
teremia in schistosomiasis patients was ﬁrst reported more
than 50 year ago, and the relationship between enterobac-
teria infections and schistosomiasis has been long studied
[3]. The prolonged enterobacterial infection is referred to
“prolonged septicemic enterobacteriosis.” The schistosome-
induced exacerbation of enterobacterial infections has also
been observed in experimental settings [77, 78]. As most
studies were conducted before the “molecular immunology
age,” the mechanisms of exacerbation of bacterial infec-
tions have not been suﬃciently elucidated. However, the
mechanisms are likely similar to those responsible for the
schistosome-induced increase in susceptibility to protozoan
parasites, that is, a reduction in Th1-dependent protective
immunity as a consequence of augmented Th2 responses.
Indeed, a Th1-inducing protozoan parasite, L. donovani, did
not aﬀect the growth of Salmonella paratyphi A in infected
hamsters [78]. Moreover, impairment of the bactericidal
function of macrophages from schistosome-infected mice
was reported [79]. In addition to the immunomodula-
tion by schistosomes, there are direct schistosome-bacteria
interactions providing worm bodies as foci for bacterial
multiplication [3, 80, 81]. Another considerable inﬂuence
of schistosomes on bacterial infections is a reduction in
vaccine eﬃcacy. The Mycobacterium bovis BCG-induced
protective response against Mycobacterium tuberculosis in
mice was reduced by S. mansoni infection [82]. The authors
also reported increased susceptibility to intravenous BCG6 Journal of Biomedicine and Biotechnology
inoculations and lung pathology in S. mansoni-infected mice
[83]. In these studies, decrease in IFN-γ and nitric oxide in
response to PPD were observed.
2.5. Viral Infections and Vaccinations. As hepatotropic vir-
uses, that is, hepatitis B virus (HBV) and hepatitis C virus
(HCV), cause liver cirrhosis during chronic infections, the
synergistic exacerbation of hepatic pathology is expectable
outcome of concurrent infections of HBV/HCV and schisto-
somes. Because of a lack of suitable animal models for infec-
tions of these hepatotropic viruses, major ﬁndings in schi-
stosome-HBV/HCV coinfections have been obtained from
epidemiological studies. Regarding HBV, schistosomiasis
(especially the severe hepatosplenic form) was correlated
withahigherfrequencyofHBVinfection[3,84,85].Thisob-
servation could be explained by an increased susceptibility to
HBV caused by schistosome infections. On the other hand,
there are reports of no relationship between schistosomiasis
and HBV [86, 87]. In addition, experiments with animals do
not support increased susceptibility to HBV in schistosomi-
asis. Some evidence comes from an experiment using wood-
chucks infected with both schistosomes and woodchuck
hepatitisvirus(WHV)[88].AsHBVandWHVbelongtothe
same family (family Hepadnaviridae), a concurrent infection
byschistosomesandWHVinwoodchucksisagoodmodelof
concurrent infections of schistosomes and HBV in humans.
The authors reported no impact of the schistosome infection
on WHV serum markers. Another paper on HBV transgenic
mice [89] reported an inhibition of HBV replication during
schistosome infection. In that study, the antiviral eﬀects
of schistosomes were attributed to IFN-γ and nitric oxide.
Overall, it seems premature to conclude the presence of cer-
tain positive or negative eﬀects of schistosomes on HBV
infection. Regarding HBV vaccines (both serum derived and
recombinant), they were immunogenic in schistosomiasis
patients although reduced responses to vaccination were
observed in hepatosplenic schistosomiasis [90–92].
IncontrasttothecontroversialeﬀectsonHBVinfections,
detrimental eﬀects of schistosomes on HCV infections have
beenclearlydemonstrated,thatis,schistosomesweakenanti-
HCV immune responses and worsen liver disease. According
tostudiesinEgypt,patientswithcoinfectionswerecharacter-
izedbyamoreadvancedliverpathology,greaterviralburden,
higher levels of anti-HCV antibodies, and progression to
chronic hepatitis [93–95]. Moreover, schistosomiasis was
shown to be inversely correlated with HCV-speciﬁc CD4+ T
cells, CD8+ T cells, and/or Th1 cytokine responses [95–100].
In addition to the modulatory eﬀects of schistosomes on
HCV-speciﬁc immune responses, SEA of S. mansoni [101]
and S. haematobium [102] were shown to enhance in vitro
viral replication in a hepatoblastoma cell line (HepG2) and
peripheral blood mononuclear cells (PBMCs), respectively.
Likewise, in other viral infections, schistosomes were shown
to suppress speciﬁc CTL and cytokine responses and to
prevent viral clearance [103–107]. It is interesting that the
granulomas in S. mansoni-infected mice provide a microen-
vironment suitable for viral expansion [107], as in the case of
a hepatic infection with the protozoan parasite L. donovani
[70].
3. Concluding Remarks
Based on the experimental and epidemiological ﬁndings re-
viewed here, it can be concluded that schistosome infections
are generally beneﬁcial to patients with intestinal helminth
infectionsanddetrimental topatientswithbacterial,viral,or
protozoan infections. In most tropical or subtropical coun-
tries where schistosomiasis is endemic, more serious infec-
tious diseases (e.g., HIV/AIDS, tuberculosis, and malaria)
arealsoendemic.Therefore,controlofschistosomiasis(espe-
cially infections of S. mansoni and S. haematobium)h a sb e e n
givenlowprioritycomparedtocontrolofsuchinfectiousdis-
eases. However, if the detrimental bystander eﬀects of schis-
tosomes on concomitant bacterial, viral, or protozoan infec-
tions are properly considered, the importance of controlling
schistosomiasis should be more emphasized.
In 2002, J. F. Bach summarized epidemiological trends of
allergic and autoimmune diseases during recent several de-
cades in developed countries [108]. According to the paper,
the prevalence of the immunological disorders such as asth-
ma, T1D, multiple sclerosis (MS), and Crohn’s disease (CD)
was increasing, whereas the prevalence of infectious diseases
such as rheumatic fever, hepatitis A, tuberculosis, mumps,
and measles was decreasing. These phenomena may be ex-
plained by the “hygiene hypothesis” in which microbial and
helminthic infections prevent immunological disorders.
Along with this hypothesis, schistosome infections are ex-
pected to prevent or alleviate symptoms of immunological
disorders. According to the experimental studies until now,
antiallergic and antiautoimmune eﬀects of schistosomes are
also plausible in humans. However, schistosomes could not
be directly used for therapeutic treatment because of their
pathogenicity. Instead, puriﬁed immunomodulatory prod-
ucts or recombinant proteins could be tested for clinical use.
Indeed, considerable numbers of helminths’ products have
been shown to protect against experimental immunological
disorders [109]. The immunomodulators exert their eﬀects
via Toll-like receptors (TLRs) and/or C-type lectin receptors
(CLRs) [109]. Taken together with the ﬁnding that systemic
administration of TLR agonists could prevent experimental
autoimmunity and allergy [110], appropriately synthesized
TLR agonists may be able to mimic or replace the prophylac-
tic or therapeutic eﬀects of schistosomes.
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